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Editorials 
Airway epithelial cells and mediators of inflammation 
There is increasing evidence to suggest that the air- 
way epithelium, which has traditionally been regarded 
as a physical barrier preventing the entry of inhaled 
noxious particles into the submucosa, may play a more 
important role in its capacity as a ‘metabolically active’ 
physico-chemical barrier, capable of expressing and/ 
or generating increased amounts of (a) inflammatory 
eicosanoids, which are potent cell activators and 
chemo-attractants, (b) pro-inflammatory cytokines 
which have profound effects on growth, differen- 
tiation, migration and activation of inflammatory 
cells, (c) specific cell adhesion molecules, which play a 
vital role in inter-tissue ‘trafficking’ of the inflamma- 
tory cells and (d) MHC class II antigens, which play 
an important role in antigen presentation to and 
subsequent activation of the T cells. 
Studies of animal (l-3) and human (45) airway 
epithelial cells have demonstrated that these are 
capable of metabolizing arachidonic acid to com- 
pounds such as leukotrienes B, and C, (LTB, and 
LTC,) and prostaglandins E, and F,, (PGE, and 
PGF,,), which have potent smooth muscle constrictor 
and leucocyte chemoattractant effects. Studies of 
exposure of airway epithelial cells to commonly 
occurring air pollutants such as ozone (0,) and 
nitrogen dioxide (NO,) and bacterial endotoxin, 
have further demonstrated that these agents can 
augment eicosanoid metabolism, with significant 
increases in PGE,, PGF,,, 6-keto-F,,, LTB,, LTC, and 
12-hydroxyeicosatetraenoic acids (12-HETEs) (3,6,7). 
Similarly, studies of airway epithelial cells and cell 
lines have demonstrated that these are also capable 
of expressing and synthesizing a large variety of cyto- 
kines, including interleukins-1, -3, -6 and -8 (IL-l, 
-3, -6 and -8) granulocyte macrophage-colony stimu- 
lating factor (GM-CSF), granulocyte-colony stimu- 
lating factor (G-CSF) and tumour necrosis factor-u 
(TNF-a) which, either directly or in conjunction with 
one another, can influence the growth, differentiation, 
migration and activation of eosinophils, neutrophils, 
mast cells, macrophages and lymphocytes (8-14). 
Recent evidence, however, suggests that there may be 
differences in the ability of epithelial cells of indi- 
viduals with or without respiratory disease, and likely 
between cells of atopic and non-atopic subjects, to 
synthesize different amounts and profiles of cytokines. 
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Studiesofculturednasal(l5,16)andbronchial(l7,18) 
epithelial cells, from allergic rhinitis and asthma 
patients, respectively, have suggested that these are 
‘activated’ to produce larger amounts of cytokines, 
such as IL-lb and GM-CSF, compared to cells from 
non-atopic non-allergic subjects. 
More recent studies of exposure of airway epithelial 
cells to non-allergic stimuli have suggested that these 
may also induce increased synthesis of the inflamma- 
tory cytokines. Studies, in our laboratory, of cultured 
human bronchial epithelial cells exposed to NO, 
(19,20) and Haemophilus influenzae (2 1), have demon- 
strated that these agents significantly increase the 
synthesis of GM-CSF, IL-8 and TNF-a, by these cells 
in vitro. The possible mechanisms of virus-induced 
respiratory illnesses have also recently been reviewed, 
and although it has been postulated that several viral- 
induced effects, including fever and inflammation, 
may be occurring through release ofpro-inflammatory 
cytokines, there is no firm evidence to support this 
hypothesis (22). It is likely, however, that factors 
which regulate the expression of TNF-a will be of 
particular significance in airway inflammation, since 
TNF-a is a multi-functional cytokine having signifi- 
cant influence on epithelial cell permeability (23) 
expression of IL-8, a major neutrophil chemotactic 
factor (24) and expression of intercellular adhesion 
molecule-l (ICAM-I), a member of the immuno- 
globulin supergene family (25,26). 
ICAM- has been shown to act as both the ligand 
and the counter receptor for leucocyte function 
antigen-l (LFA-1) expressed on leucocytes (27) and 
consequently plays a vital role in the recruitment and 
migration of inflammatory cells to sites of inflam- 
mation in the airways (28,29). Furthermore, studies of 
nasal and bronchial tissue of patients with nasal 
polyps, perennial/seasonal allergic rhinitis and 
asthma, have suggested that the expression of ICAM- 
may be upregulated in the airway epithelium, in vivo 
(30-33). Other studies have suggested that ICAM- is 
the main surface receptor for the majority of Rhino- 
virus serotypes (34) and that viruses themselves may 
up-regulate the expression of this surface protein in 
human airway epithelial cells, as demonstrated by 
increased synthesis of ICAM-1, in virus transformed- 
human tracheal (25) and bronchial (35) epithelial cells 
@ 1993 Baillike Tindall 
406 Editorial 
Allergen Air pollutants Viruses Bacteria 
/ 
Macrophage Mast cell Eosinophil Neutrophil 
Fig I Putative mechanisms ofairway inflammation. Stimulation ofepithelial cells by various agents may lead to generation of 
different cytokine profiles and subsequent activation of specific inflammatory cells. 
in vitro. More recently, our studies with Haemo- 
philus injuenzae endotoxin have suggested that this 
agent may also up-regulate the expression of ICAM- 1 
in cultured human bronchial epithelial cells, in vitro 
(36). 
Studies investigating the expression of the MHC 
class II antigens have demonstrated that in accordance 
with the findings for other cell types, human airway 
epithelial cells also have the ability to express the 
HLA-DR antigens and the genes encoding these 
antigens (37,38). Indeed, comparative studies have 
demonstrated that epithelial expression of HLA-DR 
is significantly up-regulated in bronchial and nasal 
epithelial cells of patients with asthma and nasal 
polyps, respectively, compared with expression in cells 
from normal subjects (33,39). The ability of airway 
epithelial cells to express HLA-DR antigens, however, 
suggests that these cells may play a potentially import- 
ant role in antigen processing and/or presentation 
and possibly be involved in immunoregulation via 
recognition-, activation- and proliferation- of specific 
T-lymphocyte types (Thl or Th2), which are thought 
to produce specific cytokines (14,40,41). It has been 
suggested that the Thl-like lymphocytes produce 
predominantly interleukin-2 (IL-2) IFN, and TNF-a 
and are involved in delayed-type hypersensitivity 
reactions and in the synthesis of IgM and some IgG 
subclasses. The Th2-like lymphocytes synthesize 
interleukins- 3, 4, 5, 6, 8 and 10 and also TNF-a, 
and are thought to be important in allergic-type 
inflammatory reactions and defence against parasites. 
In conclusion, it is tempting to hypothesize that in 
airway diseases, activation or dysfunction of epithelial 
cells themselves, results in attraction, maintenance and 
activation of the various inflammatory cells in the epi- 
thelium (Fig. 1). It is conceivable that in allergic airway 
disease, allergens presented by epithelial cells trigger 
the ‘Th2 cell-associated pathway’, to increase the 
transcriptional expression and synthesis of GM-CSF, 
IL-3, IL-4 and IL-5, which affect predominantly eosi- 
nophil, mast cell and macrophage cell function. On the 
other hand, non-allergic stimuli such as air pollutants, 
bacteria (endotoxin) and viruses, directly affect epi- 
thelial cells to increase the synthesis of GM-CSF, IL-8 
and TNF-a, and in addition promote the ‘Thl cell- 
associated pathway’, resulting in decreased synthesis 
of IL-3, IL-4 and IL-5 The overall effect would be to 
enhance migration and activation of neutrophils in 
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particular, and to attenuate migration and ad&Z& 
of other inflammatory cell types. 
J. L. DEVALIA AND R. J. DAVIES 
Department of Respiratory Medicine 
St Bartholomew’s Hospital 
London ECIA 7BE, U.K. 
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